FilingSEC EDGAR6-K
BioLineRx Ltd. Announces Results of Annual General Meeting
· SEC accepted
StageApproval
Filing content
Shareholders approved the re-election of directors, an increase in authorized share capital, and equity-based compensation for management at the annual general meeting.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…